# IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease

Study · id `cardio:ct-nct04849325` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04849325](<https://clinicaltrials.gov/study/NCT04849325>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04849325

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT04849325. Randomized; single masking; primary purpose treatment. Start 2021-12-09 (actual); primary completion 2024-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT04849325, source copy `cardio:ctgov-nct04849325-2022-03-17`, retrieved 2026-10-31)
- Started: 2021-12-09 (actual) (ClinicalTrials.gov record NCT04849325, source copy `cardio:ctgov-nct04849325-2022-03-17`, retrieved 2026-10-31)
- Primary completion: 2024-04 (anticipated) (ClinicalTrials.gov record NCT04849325, source copy `cardio:ctgov-nct04849325-2022-03-17`, retrieved 2026-10-31)
- Completion: 2024-10 (anticipated) (ClinicalTrials.gov record NCT04849325, source copy `cardio:ctgov-nct04849325-2022-03-17`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT04849325, source copy `cardio:ctgov-nct04849325-2022-03-17`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04849325-2022-03-17`, retrieved 2026-10-31)

## The registry's words

- Brief title: IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease
- Acronym: GENIUS
- Condition: Critical Limb Ischemia (CLI)
- Intervention (Device): Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™)
- Intervention (Device): Percutaneous Transluminal Angioplasty (PTA) Device
- Lead sponsor: Biotyx Medical (Shenzhen) Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Biotyx Medical (Shenzhen) Co., Ltd. (`cardio:org-biotyx-medical-shenzhen-co-ltd`)

## Provenance

Content hash: 2936013fb0e43b0e2a393330f4e0c7c0167fc2bc02c14a090828ace70536291d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
